One-Pot Assay Based on CRISPR/Cas13a Technology for HEV RNA Point-of-Care Testing. Fan Z, Xu L, Cao Y, Liu T, et al. J Med Virol 2024;96:e70115.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fan Z, Xu L, Cao Y, Liu T, et al. One-Pot Assay Based on CRISPR/Cas13a Technology for HEV RNA Point-of-Care Testing. J Med Virol 2024;96:e70115.
PMID: 39704190